Vagus nerve stimulation, by targeting a key phenotype (inflammation) and multiple companion cytokines in addition to IL-6 [IL-1β, TNFα, etc.] could be broadly applied to multiple types of cancer to combat immune evasion and cytokine redundancy [Soler et al., 2023] [Table 1]. Here, TNF is linked to cancer.